Shearman & Sterling and Fangda Partners have represented Chinese assisted reproductive services (ARS) provider Jinxin Fertility Group on its $390 million Hong Kong IPO, with Paul Hastings and Commerce & Finance Law Offices advising the joint sponsors and underwriters.

Cleary Gottlieb Steen & Hamilton and Li & Partners are acting for Jiangsu, China-based Hansoh Pharmaceutical Group, on its $1 billion Hong Kong initial public offering, with Clifford Chance and Tian Yuan Law Firm advising the joint sponsors and the underwriters.

Clifford Chance and Fangda Partners have advised Huatai Securities (HTSC), one of China’s largest brokerages, on the listing of its global depository receipts (GDR) through a programme linking the Shanghai Stock Exchange with the London Stock Exchange (LSE).

Squire Patton Boggs and Grandall Law Firm are acting for Chinese solar farm operator Xinyi Energy on its $465 million Hong Kong initial public offering (IPO), with Deacons and JunHe advising the underwriters, and Milbank advising the sponsor and coordinators.

Davis Polk & Wardwell and King & Wood Mallesons are acting for Luckin Coffee, China’s second largest and fastest-growing coffee network, on its $570 million Nasdaq initial public offering (IPO). The underwriters, represented by Cleary Gottlieb Steen & Hamilton and Jingtian & Gongcheng, were granted an option to purchase up to an additional 495 million ADSs.

Skadden, Arps, Slate, Meagher & Flom, Clifford Chance and CM Law Firm have represented Hong-Kong based Futu Securities International on its $90 million Nasdaq initial public offering, with Latham & Watkins and Han Kun Law Offices advising the underwriters.

Tian Yuan Law Firm has represented Offcn Education Technology, a private training firm with a market value of over $7.2 billion (50 billion RMB), on its $ 2.7 billion (18.5 billion RMB) Shenzhen initial public offering.

Clifford Chance and Commerce & Finance Law Offices have represented Tencent-backed Maoyan Entertainment, China’s top movie-ticketing platform by sales, on its $250 million Hong Kong initial public offering, with Kirkland & Ellis and Jingtian & Gongcheng advising the underwriters.

Davis Polk & Wardwell and Zhong Lun Law Firm have represented Chinese travel agency Tongcheng-Elong Holdings Limited on its HK$1.41 billion (US$180 million) Hong Kong initial public offering, with Kirkland & Ellis and Grandall Law Firm advising the underwriters.

Skadden, Arps, Slate, Meagher & Flom and Han Kun Law Offices are acting for Chinese biopharma company Innovent Biologics on its HK$3.3 billion ($421 million) listing on the Hong Kong Stock Exchange, with Davis Polk & Wardwell and Commerce & Finance Law Offices advising the underwriters.